Bonifácio Maria João, Vieira-Coelho Maria Augusta, Soares-da-Silva Patrício
Department of Research and Development, BIAL, A Av. da Siderurgia Nacional, 4745-457 S. Mamede do Coronado, Portugal
Eur J Pharmacol. 2003 Jan 24;460(2-3):163-70. doi: 10.1016/s0014-2999(02)02879-0.
The present study reports the kinetic inhibitory profile of 1-[3,4-dihydroxy-5-nitrophenyl]-2-phenyl-ethanone (BIA 3-202), a novel inhibitor of soluble catechol-O-methyltransferase (COMT) in rat liver. After an oral single dose (30 mg kg(-1)), there was a time-dependent recovery of enzyme activity from 98+/-2% inhibition at 30 min to total recovery at 24 h after treatment. The inhibitory effect produced by BIA 3-202 on soluble COMT was reversible after gel filtration of the samples. BIA 3-202 acted as a fast inhibitor of rat liver soluble COMT, interacting immediately with the enzyme after mixing. No differences were observed in the metanephrine formation rates (in nmol mg protein(-1) min(-1)) obtained without and with a 60-min preincubation with 30 nM of BIA 3-202 (1.30+/-0.02 and 1.35+/-0.03, respectively). The tight-binding nature of the inhibition produced by BIA 3-202 was evaluated by performing an Ackermann-Potter plot. The true K(i) for BIA 3-202, derived from the nonlinear regression analysis, was 0.19+/-0.02 nM. In substrate competition studies, an increase in the concentration of adrenaline resulted in a linear increase in IC(50) values for BIA 3-202. In conclusion, BIA 3-202 behaves as a reversible, potent and fast tight-binding COMT inhibitor that acts competitively at the substrate binding site of rat liver soluble COMT.
本研究报告了1-[3,4-二羟基-5-硝基苯基]-2-苯基乙酮(BIA 3-202)的动力学抑制特征,它是大鼠肝脏中可溶性儿茶酚-O-甲基转移酶(COMT)的一种新型抑制剂。口服单剂量(30 mg kg⁻¹)后,酶活性随时间从给药后30分钟时98±2%的抑制率恢复至24小时时完全恢复。样品经凝胶过滤后,BIA 3-202对可溶性COMT产生的抑制作用是可逆的。BIA 3-202是大鼠肝脏可溶性COMT的快速抑制剂,混合后能立即与该酶相互作用。在有无30 nM BIA 3-202预孵育60分钟的情况下,所测得的变肾上腺素生成速率(以nmol mg蛋白质⁻¹ min⁻¹计)无差异(分别为1.30±0.02和1.35±0.03)。通过绘制阿克曼-波特图评估了BIA 3-202产生的抑制作用的紧密结合性质。通过非线性回归分析得出,BIA 3-202的真实抑制常数(K(i))为0.19±0.02 nM。在底物竞争研究中,肾上腺素浓度增加导致BIA 3-202的半数抑制浓度(IC(50))值呈线性增加。总之,BIA 3-202是一种可逆、强效且快速紧密结合的COMT抑制剂,在大鼠肝脏可溶性COMT的底物结合位点起竞争性作用。